409 related articles for article (PubMed ID: 28594391)
1. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
2. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.
Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803
[TBL] [Abstract][Full Text] [Related]
3. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of galectin-7 in epithelial ovarian cancer.
Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
[TBL] [Abstract][Full Text] [Related]
5. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin.
van den Brûle F; Califice S; Garnier F; Fernandez PL; Berchuck A; Castronovo V
Lab Invest; 2003 Mar; 83(3):377-86. PubMed ID: 12649338
[TBL] [Abstract][Full Text] [Related]
7. Role of Galectins in Tumors and in Clinical Immunotherapy.
Chou FC; Chen HY; Kuo CC; Sytwu HK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
[TBL] [Abstract][Full Text] [Related]
8. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.
Kim HJ; Jeon HK; Cho YJ; Park YA; Choi JJ; Do IG; Song SY; Lee YY; Choi CH; Kim TJ; Bae DS; Lee JW; Kim BG
Eur J Cancer; 2012 Aug; 48(12):1914-21. PubMed ID: 22386573
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
[TBL] [Abstract][Full Text] [Related]
10. Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.
Schulkens IA; Heusschen R; van den Boogaart V; van Suylen RJ; Dingemans AM; Griffioen AW; Thijssen VL
PLoS One; 2014; 9(9):e107988. PubMed ID: 25259711
[TBL] [Abstract][Full Text] [Related]
11. Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications.
Mohamed RM; Emam A; Abdelfattah MM; Abdel-Mageed AI; Abdelhafeez MA; Helwa R
World J Surg Oncol; 2022 Sep; 20(1):276. PubMed ID: 36050693
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.
Kim MK; Sung CO; Do IG; Jeon HK; Song TJ; Park HS; Lee YY; Kim BG; Lee JW; Bae DS
Int J Clin Oncol; 2011 Aug; 16(4):352-8. PubMed ID: 21327452
[TBL] [Abstract][Full Text] [Related]
13. Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.
Labrie M; De Araujo LOF; Communal L; Mes-Masson AM; St-Pierre Y
Sci Rep; 2017 Oct; 7(1):13244. PubMed ID: 29038585
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic binding studies of galectin-1, -3 and -7.
Brewer CF
Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
Aggarwal S; Sharma SC; Das SN
Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
[TBL] [Abstract][Full Text] [Related]
16. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
17. Galectin-8 and -9 as prognostic factors for cervical cancer.
Beyer S; Wehrmann M; Meister S; Kolben TM; Trillsch F; Burges A; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Kolben T
Arch Gynecol Obstet; 2022 Oct; 306(4):1211-1220. PubMed ID: 35377045
[TBL] [Abstract][Full Text] [Related]
18. High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients.
Trebo A; Ditsch N; Kuhn C; Heidegger HH; Zeder-Goess C; Kolben T; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Hester A
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290551
[TBL] [Abstract][Full Text] [Related]
19. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
Ajani JA; Estrella JS; Chen Q; Correa AM; Ma L; Scott AW; Jin J; Liu B; Xie M; Sudo K; Shiozaki H; Badgwell B; Weston B; Lee JH; Bhutani MS; Onodera H; Suzuki K; Suzuki A; Ding S; Hofstetter WL; Johnson RL; Bresalier RS; Song S
Br J Cancer; 2018 Jan; 118(1):52-61. PubMed ID: 29136404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]